phosphatidylcholines has been researched along with itraconazole in 15 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (itraconazole) | Trials (itraconazole) | Recent Studies (post-2010) (itraconazole) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 6,440 | 653 | 2,357 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 10 (66.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Carrillo-Muñoz, AJ; Cossum, PA; del Valle, O; Miranda, Y; Quindós, G; Ruesga, MT; Tur, C; Wallace, TL | 1 |
| Baddley, JW; Moser, SA; Pappas, PG; Sutton, DA | 1 |
| Ali, LI; Carter, TH; Roy, V; Selby, GB | 1 |
| Cook, PP | 1 |
| Caillot, D; Kara-Slimane, F; Mannone, L | 1 |
| Bryant, RE; Hunter, AJ | 1 |
| Brunson, ME; Duchini, A; McHutchison, JG; Pockros, PJ; Redfield, DC | 1 |
| Brio, S; Cantón, E; Carrillo-Muñoz, AJ; del Valle, O; Guarro, J; Hernández-Molina, JM; Pemán, J; Quindós, G; Rodriguez, V; Ruesga, M; Santos, P | 1 |
| Butani, L; Jain, A | 1 |
| Frank, M; Jaradeh, SS; Ortega-Gutierrez, S; Szeder, V | 1 |
| Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA | 1 |
| Cai, L; He, K; Liu, H; Shi, Q; Woolf, TF | 1 |
| Bednar, J; Bunker, A; Dzieciuch-Rojek, M; Kepczynski, M; Kozik, B; Nowakowska, M; Poojari, C; Róg, T; Vattulainen, I; Wydro, P | 1 |
| Dimova, R; Jurkiewicz, P; Kepczynski, M; Lira, RB; Petka, R; Poojari, C; Róg, T; Wilkosz, N | 1 |
| Bunker, A; Dzieciuch-Rojek, M; Kepczynski, M; Poojari, C; Róg, T; Zak, A | 1 |
2 review(s) available for phosphatidylcholines and itraconazole
| Article | Year |
|---|---|
[Invasive aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; Drug Combinations; Humans; Immunosuppression Therapy; Itraconazole; Neuroaspergillosis; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications; Prognosis; Radiography, Thoracic; Risk Factors; Tomography, X-Ray Computed | 2001 |
Aspergillosis in liver transplant recipients: successful treatment and improved survival using a multistep approach.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Drug Combinations; Female; Humans; Inguinal Canal; Itraconazole; Liver Transplantation; Lung; Lung Diseases, Fungal; Lymphatic Diseases; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Survival Rate | 2002 |
1 trial(s) available for phosphatidylcholines and itraconazole
| Article | Year |
|---|---|
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2008 |
12 other study(ies) available for phosphatidylcholines and itraconazole
| Article | Year |
|---|---|
In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Deoxycholic Acid; Drug Carriers; Drug Combinations; Fluconazole; Humans; Itraconazole; Liposomes; Microbial Sensitivity Tests; Nystatin; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Microascus cinereus (Anamorph scopulariopsis) brain abscess in a bone marrow transplant recipient.
Topics: Adult; Amphotericin B; Ascomycota; Bone Marrow Transplantation; Brain Abscess; Central Nervous System Fungal Infections; Craniotomy; Drug Combinations; Female; Graft vs Host Disease; Humans; Itraconazole; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Drug Combinations; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lymphoma, Follicular; Male; Mucormycosis; Opportunistic Infections; Pancytopenia; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Amphotericin B lipid complex for the treatment of recurrent blastomycosis of the brain in a patient previously treated with itraconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Blastomycosis; Central Nervous System Fungal Infections; Cerebellar Diseases; Drug Combinations; Female; Humans; Itraconazole; Phosphatidylcholines; Phosphatidylglycerols; Recurrence | 2001 |
Abdominal wall mucormycosis successfully treated with amphotericin and itraconazole.
Topics: Abdominal Muscles; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Inflammatory Bowel Diseases; Itraconazole; Middle Aged; Mucormycosis; Phosphatidylcholines; Phosphatidylglycerols; Pyoderma Gangrenosum; Rhizopus | 2002 |
Comparison of in vitro antifungal activities of amphotericin B lipid complex with itraconazole against 708 clinical yeast isolates and opportunistic moulds determined by National Committee for Clinical Laboratory Standards methods M27-A and M38-P.
Topics: Amphotericin B; Antifungal Agents; Culture Media; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Quality Control; Yeasts | 2002 |
Severe hyperphosphatemia resulting from high-dose liposomal amphotericin in a child with leukemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Calcium Carbonate; Candidiasis; Cellulitis; Child; Drug Carriers; Female; Headache; Humans; Hyperparathyroidism, Secondary; Immunocompromised Host; Itraconazole; Liposomes; Mucormycosis; Orbital Diseases; Parathyroid Hormone; Phosphates; Phosphatidylcholines; Phosphatidylglycerols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Seizures; Sinusitis; Vitamin D | 2003 |
CNS blastomycosis in a young man working in fields after Hurricane Katrina.
Topics: Adult; Agricultural Workers' Diseases; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Brain; Cognition Disorders; Contrast Media; Deoxycholic Acid; Disasters; Drug Combinations; Encephalitis; Facial Dermatoses; Gadolinium; Humans; Itraconazole; Louisiana; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Phosphatidylcholines; Phosphatidylglycerols; Skin Ulcer | 2007 |
Inhibition of MDR3 Activity in Human Hepatocytes by Drugs Associated with Liver Injury.
Topics: ATP Binding Cassette Transporter, Subfamily B; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Deuterium; Hepatocytes; Humans; Itraconazole; Phosphatidylcholines; Tandem Mass Spectrometry; Taurocholic Acid; Verapamil | 2015 |
Effects of Membrane PEGylation on Entry and Location of Antifungal Drug Itraconazole and Their Pharmacological Implications.
Topics: Antifungal Agents; Chemistry, Pharmaceutical; Drug Delivery Systems; Fluorescence; Itraconazole; Lipid Bilayers; Liposomes; Membranes; Phosphatidylcholines; Polyethylene Glycols; Polymers; Protective Agents; Solubility; Surface Properties | 2017 |
Behavior of the DPH fluorescence probe in membranes perturbed by drugs.
Topics: Antifungal Agents; Diphenylhexatriene; Fluorescence Polarization; Fluorescent Dyes; Hydrophobic and Hydrophilic Interactions; Itraconazole; Lipid Bilayers; Molecular Dynamics Simulation; Phosphatidylcholines; Surface Properties | 2019 |
Cholesterol Reduces Partitioning of Antifungal Drug Itraconazole into Lipid Bilayers.
Topics: Antifungal Agents; Cholesterol; Glycerol; Itraconazole; Lipid Bilayers; Phosphatidylcholines; Phosphorylcholine | 2020 |